FDA labels
Search the openFDA drug-label export by label identifier, NDC, application, RxCUI, UNII, product name, or manufacturer.
Cross-check layer: openFDA label JSON supports search and identifier cross-checks. DailyMed SPL remains FDA.report’s canonical label presentation.
Label matches#
| Label | Generic name | Manufacturer | SPL set ID | Effective date | Safety fields | Match |
|---|---|---|---|---|---|---|
| NAROPIN | ROPIVACAINE HYDROCHLORIDE | Henry Schein, Inc. | 6a2f1f6d-026f-4f39-aee0-5b75b8eb5c02 | 2026-07-22 | Warnings, Adverse reactions | Name/manufacturer search |
| Naropin | ROPIVACAINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | cb6583ff-cde4-4280-aa5b-0bea2b844792 | 2026-07-17 | Warnings, Adverse reactions | Name/manufacturer search |
| Naropin | ROPIVACAINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | dff4a1e4-4b2a-4a64-b6d8-ea470dee88f7 | 2024-08-15 | Warnings, Adverse reactions | Name/manufacturer search |
| Naropin | ROPIVACAINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | 23d2d448-a744-4877-9f2d-7e57c198da89 | 2024-08-06 | Warnings, Adverse reactions | Name/manufacturer search |
| Naropin | ROPIVACAINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | c6613708-c1f7-4f5c-91a3-ebbc1d7905c6 | 2024-07-10 | Warnings, Adverse reactions | Name/manufacturer search |
| Naropin | ROPIVACAINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | 56dfabf7-f7a8-4601-b17a-cb16fb995b0f | 2024-05-22 | Warnings, Adverse reactions | Name/manufacturer search |